PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of f1000resSubmitAuthor GuidelinesAboutAdvisory PanelF1000ResearchView this article
 
F1000Res. 2013; 2: 35.
Published online 2013 February 7. doi:  10.12688/f1000research.2-35.v1
PMCID: PMC3829120

Longitudinal RNA sequencing of the deep transcriptome during neurogenesis of cortical glutamatergic neurons from murine ESCs

Abstract

Using paired-end RNA sequencing, we have quantified the deep transcriptional changes that occur during differentiation of murine embryonic stem cells into a highly enriched population of glutamatergic cortical neurons. These data provide a detailed and nuanced account of longitudinal changes in the transcriptome during neurogenesis and neuronal maturation, starting from mouse embryonic stem cells and progressing through neuroepithelial stem cell induction, radial glial cell formation, neurogenesis, neuronal maturation and cortical patterning. Understanding the transcriptional mechanisms underlying the differentiation of stem cells into mature, glutamatergic neurons of cortical identity has myriad applications, including the elucidation of mechanisms of cortical patterning; identification of neurogenic processes; modeling of disease states; detailing of the host cell response to neurotoxic stimuli; and determination of potential therapeutic targets. In future work we anticipate correlating changes in longitudinal gene expression to other cell parameters, including neuronal function as well as characterizations of the proteome and metabolome. In this data article, we describe the methods used to produce the data and present the raw sequence read data in FASTQ files, sequencing run statistics and a summary flatfile of raw counts for 22,164 genes across 31 samples, representing 3-5 biological replicates at each timepoint. We propose that this data will be a valuable contribution to diverse research efforts in bioinformatics, stem cell research and developmental neuroscience studies.

Objectives

Transcriptional profiling by RNA sequencing (RNAseq) enables the sensitive and accurate characterization of the transcriptome 14. Following enumeration of reads, various methods are available to normalize counts, estimate probability distributions and identify differential gene expression between biological conditions 3, 5, 6. RNAseq has the added advantages of being extremely high-throughput and relatively inexpensive, with a high signal-to-noise ratio and a dynamic range encompassing 4–5 orders of magnitude. This combination of throughput and sensitivity enables the detection of rare transcripts from nanograms of RNA.

We have described a method to produce large quantities of highly enriched, electrically active glutamatergic neurons (ESNs) from suspension-adapted mouse embryonic stem cells (ESCs) 7, 8. This technique is a modification of the 4/4 method, and is based on the spatiotemporal changes in morphogens that occur during neural induction and patterning 911. In this method, neuroepithelial stem cells (NESCs) are derived from ESCs by the withdrawal of leukemia inhibitory factor (LIF), then induced to undergo neurogenesis and neural patterning by supplementation with all- trans retinoic acid (RA) in the presence of fetal bovine serum 12. We have modified the 4/4 method to include feeder cell-free, suspension culture of ESNs; differentiation under rotary conditions to normalize the intra-aggregate environment; and neuronal induction and neural induction and patterning using 6 µM RA. These refinements have resulted in a facile and economical method to generate large quantities of highly enriched glutamatergic neurons 13. Using immunocytochemistry, we have shown that ESNs are composed mostly of glutamatergic neurons (~95%), with about 5% GABAergic neurons, and no evidence of dopaminergic, serotonergic, cholinergic or glycinergic subtypes 7. Expression profiling using RNA sequencing has confirmed that derived cultures are primarily glutamatergic, and identified the abundant expression of a wide range of cortical markers, including reelin, Pax6, Otx1, Ctip2 and Cux1/2 1319.

Although aspects of corticogenesis have been replicated in vitro by the directed differentiation of pluripotent stem cells, spatiotemporal changes in gene expression responsible for regionalization and apical-to-basal patterning of the cerebral cortex are not well understood 2022. The embryological origin of the cerebral cortex is the telencephalon, which is the most anterior structure of the mammalian neural tube 23. Cortical glutamatergic neurons are generated by proliferation and laminar patterning of the dorsal telencephalon, whereas inhibitory GABAergic neurons derive from the ventral telencephalon and migrate tangentially into cortical layers 24, 25. Our ability to derive predominantly glutamatergic neurons that express markers of the telencephalon and all six cortical layers is consistent with an in vitro model of the developing telencephalon and cortical layer formation 23. We propose to apply this model to identify the temporal changes in gene and isoform expression associated with neural patterning and corticogenesis. If successful, we intend to use ESNs to functionally interrogate the roles of individual genes in executing the transcriptional programs underlying the formation of the cerebral cortex.

To evaluate the transcriptional changes associated with differentiation of cortical glutamatergic neurons, we conducted a longitudinal expression profile of the deep transcriptome during neurogenesis from days in vitro (DIV) -8 to 28, where DIV 0 corresponds to the end of differentiation. High quality RNA was isolated from ESCs (DIV -8; n=4); neuroepithelial stem cells (DIV -4; n=3); radial glia (DIV 0; n=3); developmental stage (DS) I/II neurons (DIV 1; n=4); DS III/IV neurons (DIV 7; n=5); and maturing DS IV/V neurons at DIV 16 (n=4); DIV 21 (n=4); and DIV 28 (n=4). The summary data, including quality scores, are presented in Data File 1, and the raw transcript read counts for each biological replicate are presented in Data File 2. The FASTQ files generated for each biological replicate are available at the Sequence Read Archive (SRA), a freely accessible database provided by NCBI ( http://www.ncbi.nlm.nih.gov/sra/), under the accession number PRJNA185305.

In addition to providing the basis for a study to characterize transcriptional processes involved in corticogenesis and neuronal maturation, we can foresee several other applications for this data. First, the identification of genes and isoforms that exhibit differential expression in synchronization with known markers is expected to provide novel insight into molecular mechanisms of neurogenesis and neural patterning. Second, a few algorithms are available for statistical determination of differential gene expression within longitudinal data sets. The depth and quality of these data suggests it may be well-suited for the development and validation of such methods. Third, we envision this dataset facilitating inter-specific comparisons of transcription during neurogenesis and corticogenesis, providing insight into transcriptional mechanisms common to and unique in the evolution of the mammalian cerebral cortex. For these reasons, we are making this data publically available for research efforts in bioinformatics, stem cell research and developmental neuroscience studies.

Materials and methods

Suspension adaptation and continuous culture of mouse ESCs

ESCs were adapted to feeder cell-free, suspension culture and maintained as previously described 7, 13. In brief, aliquots of R1 ESCs (ATCC, Manassas, VA) were thawed and maintained at 37°C at 5% CO 2 in 90% relative humidity in 10 cm bacterial plates in ESM (Knockout DMEM supplemented with 100 µM β-mercaptoethanol, 0.1mM nonessential amino acids, 2.0 mM L-glutamine, 5000 units/mL penicillin/streptomycin, 1000 units/mL recombinant mouse LIF [all Life Technologies, Carlsbad, CA] and 15% ES qualified fetal calf serum [ATCC, Manassas, VA]) 26. Cells were passaged once aggregates first became clearly visible to the naked eye (4–8 days) and maintained for at least 5 passages prior to differentiation. For passaging, aggregates were allowed to settle by gravity, washed once with 0.5 mL PBS and dissociated for 3 min at 37°C with 0.5 ml of TrypLE Express (Life Technologies). Dissociation was terminated by addition of 0.5 mL ESM followed by gently trituration with a P1000 pipette to achieve a single-cell suspension. ESNs were counted manually using a hemocytometer and ~1.5×10 6 mESCs were transferred to 10 mL ESM in a fresh 10 cm bacterial dish.

Neuronal differentiation

ESCs were differentiated into neurons between 5–30 passages after adaptation to suspension culture. A modified 4/4 protocol was used for neuron differentiation 7, 27. Following routine sub-passaging, 3.5×10 6 mouse ESCs were transferred to 30 mL differentiation medium (ESM modified to contain 10% ESC-qualified fetal calf serum and without LIF) in a 10 cm ultra-low attachment suspension culture dish (Corning, Lowell, MA). This was designated as DIV -8. Differentiating aggregates were maintained on a rotary shaker at 45 rpm at 37°C, 5% CO2 and 90% relative humidity. Complete media changes were conducted every 48 h, and media was supplemented with 6 µM retinoic acid (Sigma-Aldrich) at DIV -4 and DIV -2.

On DIV 0, aggregates were dissociated with TrypLE Express for 5 min at 37°C. Trypsinization was halted with 5 mL of 1% soybean trypsin inhibitor (Life Technologies), the aggregates were gently dissociated by trituration with a 10 mL pipet, and the cell suspension was filtered through a 40 µm cell strainer (Thermo Scientific, Waltham, MA). Cells were pelleted for 5 min at 300 x g, washed in N2 medium (Neurobasal-A medium with 1 x N2 vitamins, 2 mM glutamine and antibiotics [Life Technologies]) and counted manually using a hemocytometer. Neuronal progenitors were plated at 1.5×10 6 cells/cm 2 in poly-D coated dishes. Complete washes with N2 medium were conducted at 4 h and 24 h to remove residual serum and non-adherent cells. At DIV 2, N2 was replaced with B27 medium (Neurobasal-A supplemented with antibiotics, 2 mM glutamine and 1 x B27 vitamins [Life Technologies]). Subsequently, ESNs underwent full medium changes with B27 on DIV 4, 8 and 12. On DIV 8 the media was supplemented with 30 µM 5-fluoro-2’-deoxyuridine and 70 µM Uridine (Sigma-Aldrich) to select against any remaining glia. Following DIV 12, ESNs were left undisturbed until RNA harvest. Cultures remained healthy and viable until at least DIV 28 under these conditions.

Expression profiling

Neurons were harvested from 6 cm dishes at DIV -8, -4, 0, 1, 7, 16, 21 and 28 (n=3 to 5) and RNA was isolated by QIAcube (Qiagen, Valencia, CA) using the RNeasy mini kit protocol (Qiagen) and submitted to Expression Analysis, Inc. (Durham, NC) for library preparation and sequencing. Typical recovery was ~3 µg per 6 cm dish, with an RNA integrity number exceeding 8 and a 260:280 of 1.8 – 2.2. PolyA+ RNA was purified from 500 ng of total RNA using polyA selection, chemically fragmented and reverse transcribed using random hexamers. This was followed by second strand synthesis and end repair. Libraries were prepared for paired-end sequencing using the TruSeq™ RNA sample prep kits (Illumina, San Diego, CA) per manufacturer’s instructions, and library size and integrity were determined using the Agilent Bioanalyzer 2100 (Santa Clara, CA). Libraries were bound to flow cell surfaces using the Standard Cluster Generation Kit v5 (Illumina). Flow cells were transferred to the Illumina HiSeq 2000 and run using TruSeq SBS Kits (Illumina). Paired-end sequencing data were generated over 2x50 sequencing cycles. Sequence information and quality scores are available at SRA in FASTQ format, with the forward and reverse reads appended with an "F" or "R" (e.g., DIV7.1F and DIV7.1R). Raw sequence reads were aligned using the University of California, Santa Cruz’s mouse knownGENE track, and transcriptome abundance estimation was performed on completed alignments using RSEM (RNA-Seq by Expectation Maximization) 28. A summary flatfile containing the total raw reads for each gene in each biological replicate is presented in Data File 2. Genes were excluded if no reads occurred in any biological sample.

Data File 1: summary data:

RNA-sequencing by Expectation Maximization summary of quality metrics for paired-end Illumina runs. The last column indicates the filenames of the corresponding FASTQ files available at Sequence Read Archive, appended with an “F” for the forward sequence read or an “R” for the reverse sequence read.

Data File 2: raw transcript read counts:

RNA-Sequencing by Expectation Maximization-estimated total counts for all genes in biological replicates of days in vitro (DIV) -8, -4, 0, 1, 7, 16, 21 and 28 samples. Genes for which no reads were detected in any biological sample were excluded.

Acknowledgements

We thank Angela Adkins, Cindy Kronman and Marian Nelson (USAMRICD, MD) for administrative, logistical and technical assistance. We also thank Expression Analysis, Inc. (Durham, NC) for assistance with RNA sequence generation. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government.

Notes

v1; ref status: indexed

Funding Statement

This work was funded by the National Institutes of Health National Institute of Allergy and Infectious Diseases (IAA number AOD12058-0001-0000) and the Defense Threat Reduction Agency – Joint Science and Technology Office, Medical S&T Division (grant number CBM.THRTOX.01.10.RC.021). This research was performed while IMG held a Defense Threat Reduction Agency-National Research Council Research Fellowship Award and KSH held a National Research Council Research Associateship Award.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Bullard JH, Purdom E, Hansen KD, et al. : Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010;11:94. doi: 10.1186/1471-2105-11-94. [PMC free article] [PubMed] [Cross Ref]
2. Griffith M, Griffith OL, Mwenifumbo J, et al. : Alternative expression analysis by RNA sequencing. Nat Methods. 2010;7(10):843–847. doi: 10.1038/nmeth.1503. [PubMed] [Cross Ref]
3. Marioni JC, Mason CE, Mane SM, et al. : RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008;18(9):1509–1517. doi: 10.1101/gr.079558.108. [PubMed] [Cross Ref]
4. Hebenstreit D, Fang M, Gu M, et al. : RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol Syst Biol. 2011;7:497. doi: 10.1038/msb.2011.28. [PMC free article] [PubMed] [Cross Ref]
5. Sultan M, Schulz MH, Richard H, et al. : A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science. 2008;321(5891):956–960. doi: 10.1126/science.1160342. [PubMed] [Cross Ref]
6. Robinson MD, Smyth GK.: Moderated statistical tests for assessing differences in tag abundance. Bioinformatics. 2007;23(21):2881–2887. doi: 10.1093/bioinformatics/btm453. [PubMed] [Cross Ref]
7. McNutt P, Celver J, Hamilton T, et al. : Embryonic stem cell-derived neurons are a novel, highly sensitive tissue culture platform for botulinum research. Biochem Biophys Res Commun. 2011;405(1):85–90. doi: 10.1016/j.bbrc.2010.12.132. [PubMed] [Cross Ref]
8. Hubbard KS, Gut IM, Lyman ME, et al. : High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research. BMC Neurosci. 2012;13:127. doi: 10.1186/1471-2202-13-127. [PMC free article] [PubMed] [Cross Ref]
9. Bain G, Kitchens D, Yao M, et al. : Embryonic stem cells express neuronal properties in vitro. Dev Biol. 1995;168(2):342–357. doi: 10.1006/dbio.1995.1085. [PubMed] [Cross Ref]
10. Bibel M, Richter J, Lacroix E.: et al. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat Protoc. 2007;2(5):1034–1043. doi: 10.1038/nprot.2007.147. [PubMed] [Cross Ref]
11. Glaser T, Brustle O.: Retinoic acid induction of ES-cell-derived neurons: the radial glia connection. Trends Neurosci. 2005;28(8):397–400. doi: 10.1016/j.tins.2005.05.008. [PubMed] [Cross Ref]
12. Levine AJ, Brivanlou AH.: Proposal of a model of mammalian neural induction. Dev Biol. 2007;308(2):247–256. doi: 10.1016/j.ydbio.2007.05.036. [PMC free article] [PubMed] [Cross Ref]
13. Hubbard KS, Gut IM, Lyman ME, et al. : High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research. BMC Neurosci. 2012;13:127. doi: 10.1186/1471-2202-13-127. [PMC free article] [PubMed] [Cross Ref]
14. Germain N, Banda E, Grabel L.: Embryonic stem cell neurogenesis and neural specification. J Cell Biochem. 2010;111(3):535–542. doi: 10.1002/jcb.22747. [PubMed] [Cross Ref]
15. Weimann JM, Zhang YA, Levin ME, et al. : Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets. Neuron. 1999;24(4):819–831. doi: 10.1016/S0896-6273(00)81030-2. [PubMed] [Cross Ref]
16. Chen B, Schaevitz LR, McConnell SK.: Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc Natl Acad Sci U S A. 2005;102(47):17184–17189. doi: 10.1073/pnas.0508732102. [PubMed] [Cross Ref]
17. Meyer G, Goffinet AM.: Prenatal development of reelin-immunoreactive neurons in the human neocortex. J Comp Neurol. 1998;397(1):29–40. doi: 10.1002/(SICI)1096-9861(19980720)397:1<29::AID-CNE3>3.0.CO;2-K. [PubMed] [Cross Ref]
18. Georgala PA, Manuel M, Price DJ.: The generation of superficial cortical layers is regulated by levels of the transcription factor Pax6. Cereb Cortex. 2011;21(1):81–94. doi: 10.1093/cercor/bhq061. [PMC free article] [PubMed] [Cross Ref]
19. Li N, Zhao CT, Wang Y, et al. : The transcription factor Cux1 regulates dendritic morphology of cortical pyramidal neurons. PLoS One. 2010;5(5):e10596. doi: 10.1371/journal.pone.0010596. [PMC free article] [PubMed] [Cross Ref]
20. Gaspard N, Bouschet T, Hourez R, et al. : An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature. 2008;455(7211):351–357. doi: 10.1038/nature07287. [PubMed] [Cross Ref]
21. Hansen DV, Rubenstein JL, Kriegstein AR.: Deriving excitatory neurons of the neocortex from pluripotent stem cells. Neuron. 2011;70(4):645–660. doi: 10.1016/j.neuron.2011.05.006. [PMC free article] [PubMed] [Cross Ref]
22. Jing Y, Machon O, Hampl A, et al. : In vitro differentiation of mouse embryonic stem cells into neurons of the dorsal forebrain. Cell Mol Neurobiol. 2011;31(5):715–727. doi: 10.1007/s10571-011-9669-2. [PMC free article] [PubMed] [Cross Ref]
23. Sansom SN, Livesey FJ.: Gradients in the brain: the control of the development of form and function in the cerebral cortex. Cold Spring Harb Perspect Biol. 2009;1(2):a002519. doi: 10.1101/cshperspect.a002519. [PMC free article] [PubMed] [Cross Ref]
24. Butler AB.: The evolution of the dorsal pallium in the telencephalon of amniotes: cladistic analysis and a new hypothesis. Brain Res Rev. 1994;19(1):66–101. doi: 10.1016/0165-0173(94)90004-3. [PubMed] [Cross Ref]
25. Flames N, Marin O.: Developmental mechanisms underlying the generation of cortical interneuron diversity. Neuron. 2005;46(3):377–381. doi: 10.1016/j.neuron.2005.04.020. [PubMed] [Cross Ref]
26. Nagy A, Rossant J, Nagy R, et al. : Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993;90(18):8424–8428. doi: 10.1073/pnas.90.18.8424. [PubMed] [Cross Ref]
27. Bibel M, Richter J, Schrenk K, et al. : Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci. 2004;7(9):1003–1009. doi: 10.1038/nn1301. [PubMed] [Cross Ref]
28. Li B, Dewey CN.: RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi: 10.1186/1471-2105-12-323. [PMC free article] [PubMed] [Cross Ref]
F1000Res. 2013; 2: 35.
Published online 2013 February 7. doi:  10.12688/f1000research.2-35.v1

Referee response for version 1

The depth and temporal nature of the dataset presented in this paper will be beneficial to any researcher interested in cortical development in general, and potentially lead to many new insights and avenues to pursue. 

A point of note, in my experience differences in passage number of the cells used for differentiation can affect gene expression levels throughout. The authors state “ESCs were differentiated into neurons between 5-30 passages after adaptation to suspension culture.”, I wonder if that is why the DIV21 samples cluster in between the DIV16 and DIV28 when performing a PCA analysis on the transcript read counts (obtained from Data File 2)? 

Related question, how raw are the transcript read counts in Data File 2, as I thought raw counts would have to be integers whereas the counts given have decimal points? 

Finally, with regard to the previous Ref Report (Ragsdale and Albertin; 12 March 2013), have you considered comparative analysis using the Allen Brain Atlas/ Mouse Brain expression data for the thalamic and cortical areas and see which region your samples resemble most?

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

F1000Res. 2013; 2: 35.
Published online 2013 February 7. doi:  10.12688/f1000research.2-35.v1

Referee response for version 1

Cliff Ragsdale, Referee1 and Caroline Albertin, Co-referee2

There are a growing number of protocols for differentiating stem cells into particular neural cell types. This paper demonstrates the great potential of RNAseq technologies for assessing the identities of such differentiated cells in culture. The authors’ goal is an in vitro population of 'glutamatergic cortical neurons'. Although many of the genes catalogued show the anticipated profiles across the differentiation process ( Otx2 abundance decreases with DIV while Kcnh5 reads increase), the dataset also demonstrates that this culture protocol may not be the best for 'glutamatergic cortical neuron' study as transcripts for the predominant cortical vesicular glutamate transporter gene, Vglut1/Slc17a7, are barely detected in the differentiated cell populations.

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.


Articles from F1000Research are provided here courtesy of F1000 Research Ltd